Lakefront Biotherapeutics (LKFT) Interest Coverage Ratio (2016 - 2026)
Lakefront Biotherapeutics (LKFT) posted quarterly Interest Coverage Ratio of 464.99 for Q1 2026, up 128.53% year-on-year from 203.47 in Q1 2025, and up 88.09% on a QoQ basis from 247.21 in Q4 2025.
Lakefront Biotherapeutics (LKFT) Interest Coverage Ratio (2016 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Interest Coverage Ratio for 11 consecutive years, with 464.99 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio rose 128.53% year-over-year to 464.99 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 352.98 (up 175.54% YoY) and the FY2025 annual result came in at 285.34, up 238.17% from the prior year.
- Interest Coverage Ratio grew to 464.99 in Q1 2026 per LKFT's latest filing, from 247.21 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for LKFT reached as high as 464.99 in Q1 2026 and fell as low as 0.16 in Q4 2022.
- A 5-year average of 167.2 and a median of 197.44 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio soared 48990.5% — and 2024, when it tumbled 38.31%.
- Year by year, Interest Coverage Ratio stood at 0.16 in 2022, then surged by 48990.5% to 76.89 in 2023, then slumped by 38.31% to 47.44 in 2024, then jumped by 421.11% to 247.21 in 2025, then surged by 88.09% to 464.99 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 464.99, 247.21, and 197.44 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn | 464.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 464.99 |
| Dec 31, 2025 | 247.21 |
| Sep 30, 2025 | 197.44 |
| Jun 30, 2025 | 306.97 |
| Mar 31, 2025 | 203.47 |
| Dec 31, 2024 | 47.44 |
| Sep 30, 2024 | 271.97 |
| Jun 30, 2024 | 270.47 |
| Mar 31, 2024 | 76.69 |
| Dec 31, 2023 | 76.89 |
| Mar 31, 2023 | 4.82 |
| Dec 31, 2022 | 0.16 |
| Mar 31, 2022 | 5.03 |
| Jun 30, 2021 | 5.74 |
| Mar 31, 2021 | 4.48 |
| Jun 30, 2020 | 37.02 |
| Mar 31, 2020 | 1.86 |
| Dec 31, 2019 | -11.79 |
| Sep 30, 2019 | -10.17 |
| Jun 30, 2019 | 30.14 |